Dr. Kathuria is a pulmonary, critical care, and sleep physician, an implementation scientist, and an expert on tobacco dependence. Her clinical and research efforts are in reducing health disparities by developing, implementing, and studying the outcomes of innovative programs that focus on teachable moments to promote health behavior change in tobacco use, the leading cause of preventable disease. She is a PI or Co-I on several pilot projects using various platforms to improve access to guideline recommended treatment. She recently conducted a randomized controlled trial funded by the American Lung Association (Lung Cancer Discovery Award) using an inpatient nurse-driven intervention to promote smoking cessation and lung cancer screening.
Dr. Kathuria has developed and directs the Tobacco Treatment Center at Boston Medical Center, a program that brings together a multidisciplinary team of health professionals who specialize in helping smokers quit cigarettes. The team provides tobacco dependence consultation on >1500 hospitalized smokers each year. For this work, she received the inaugural Evans Clinical Innovator Award relating to efforts to treat tobacco dependence in low SES populations. She received funding from the Evans Center for Implementation and Improvement Sciences to assess outcomes related to implementation of the program.
Dr. Kathuria has chaired a national project sponsored by the American Thoracic Society (ATS) to prioritize research needs to optimize smoking cessation in the context of lung cancer screening and is an invited member of the American Cancer Society Tobacco Cessation Task Group (National Lung Cancer Round Table) tasked to improve implementation of tobacco treatment in lung cancer screening programs. She is on an ATS panel that has developed an updated clinical tobacco treatment guideline, and is chairing a committee through the American College of Chest Physicians to develop a national clinical guideline on implementing inpatient tobacco treatment services. Dr. Kathuria has been appointed by the ATS president to serve as chair on the Tobacco Action Committee to help organize educational, advocacy and policy activities relating to tobacco use.
Diversity, Equity, Inclusion and Accessibility
I have served as a Bias Reduction in Internal Medicine (BRIM) implementer and have completed a web-based course “Breaking the Bias Habit”. I continue to benefit from ongoing training in this area. For example in 2022, I completed Lift Training for Clinician Leaders, focused on integrating equity, vitality, and inclusion into our daily interactions and participate in monthly seminars that promote diversity and equity for the Pulmonary Center.
I have used my training to help promote diversity, equity, and inclusion nationally through the various committees I lead through the American Thoracic Society (ATS). In my role as chair of the ATS Tobacco Action Committee and chair of the Thoracic Oncology Assembly Planning Committee, I strive to identify and develop committee member that promote diversity, equity, and inclusion. In addition, I was a committee member that helped develop an ATS Research Policy Statement on Interventions to mitigate health inequities in lung nodule evaluation.
The goal of my research is to improve patient outcomes in low socioeconomic status (SES) patients through implementing patient-centered programs, particularly in patients with tobacco dependence. I strive to ensure that that socially disadvantaged individuals are represented in research studies. Locally, regionally and nationally, my clinical and research interests and advocacy efforts focus on interventions and policies to mitigate heath inequities in tobacco use and treatment, lung cancer screening, and lung nodule evaluation.
I am a member of the Massachusetts Collaborative for Tobacco Recovery (MCTR) tasked to disseminate and implement recommendations that lessen the burden of tobacco use in socially disadvantaged populations. Through my roles in ATS and ACCP, my work focuses on promoting strategies to address system-level factors, as well as clinician and patient factors, such as social determinants of health, with the goal of reducing lung cancer disparities. Particularly important is the FDA’s proposed rules to ban characterizing flavors from cigarettes and all characterizing flavors – other than tobacco flavor – from cigars will improve health equity.
Member
Boston University
BU-BMC Cancer Center
Member
Boston University
Pulmonary Center
Member
Boston University
Evans Center for Interdisciplinary Biomedical Research
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
Implementing Effective Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease03/15/2022 - 02/28/2027 (Subcontract PI)
Baystate Medical Center NIH NHLBI1R01HL15685-01A1
Capitalizing on hospitalization to engage low SES smokers in LDCT screening07/01/2017 - 12/31/2019 (PI)
American Lung Association
In Vivo Tagging of Lung Epithelial Cells to Define the Early Steps of Tumor Cell Dissemination09/15/2013 - 09/14/2015 (PI)
Department of Defense/Army Medical Research Acquisition Activity
Identification and Function of Ets Target Genes Involved in Lung Cancer Progression09/15/2010 - 09/14/2013 (PI)
Department of Defense
Molecular Regulation of Caveolin-1 in Lung Cancer07/01/2000 - 06/30/2008 (PI)
American Lung Association
Regulation of Caveolin-1 In Lung Tumors and Cell Lines07/01/2004 - 06/30/2006 (PI)
American Lung Association
Caveolin-1 Transcriptional Regulation in Lung Cell Lines07/07/2003 - 06/30/2004 (PI)
NIH/National Heart, Lung, and Blood Institute1 F32 HL73605 01
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Lopes LC, Zhang Y, Ross S, Fulone I, Zhu M, O'Brien KK, Pavalagantharajah S, Leone FT, Sachs DPL, Kathuria H, Murray RL, Zhang YQ. Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2022 Dec; 19(12):2077-2086. PMID: 36129426
-
Kathuria H. Electronic Cigarette Use, Misuse, and Harm. Med Clin North Am. 2022 Nov; 106(6):1081-1092. PMID: 36280334
-
Kathuria H, Shankar D, Cobb V, Newman J, Bulekova K, Werntz S, Borrelli B. Integrating Social Determinants of Health With Tobacco Treatment for Individuals With Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging. JMIR Form Res. 2022 Sep 01; 6(9):e36919.View Related Profiles. PMID: 36048509; PMCID: PMC9478816; DOI: 10.2196/36919;
-
Kathuria H, Gunawan A, Spring M, Aijaz S, Cobb V, Fitzgerald C, Wakeman C, Howard J, Clancy M, Foreman AG, Truong V, Wong C, Steiling K, Lasser KE, Bulekova K, Wiener RS. Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials. Cancer Causes Control. 2022 Nov; 33(11):1373-1380.View Related Profiles. PMID: 35997854; DOI: 10.1007/s10552-022-01620-8;
-
Xie W, Tackett AP, Berlowitz JB, Harlow AF, Kathuria H, Galiatsatos P, Fetterman JL, Cho J, Blaha MJ, Hamburg NM, Robertson RM, DeFilippis AP, Hall ME, Bhatnagar A, Benjamin EJ, Stokes AC. Association of Electronic Cigarette Use with Respiratory Symptom Development among U.S. Young Adults. Am J Respir Crit Care Med. 2022 Jun 01; 205(11):1320-1329.View Related Profiles. PMID: 35089853; PMCID: PMC9873120; DOI: 10.1164/rccm.202107-1718OC;
-
Shankar D, Borrelli B, Cobb V, Quintiliani LM, Palfai T, Weinstein Z, Bulekova K, Kathuria H. Text-messaging to promote smoking cessation among individuals with opioid use disorder: quantitative and qualitative evaluation. BMC Public Health. 2022 Apr 06; 22(1):668.View Related Profiles. PMID: 35387648; PMCID: PMC8988312; DOI: 10.1186/s12889-022-13008-z;
-
Hayes D, Board A, Calfee CS, Ellington S, Pollack LA, Kathuria H, Eakin MN, Weissman DN, Callahan SJ, Esper AM, Crotty Alexander LE, Sharma NS, Meyer NJ, Smith LS, Novosad S, Evans ME, Goodman AB, Click ES, Robinson RT, Ewart G, Twentyman E. Pulmonary and Critical Care Considerations for e-Cigarette, or Vaping, Product Use-Associated Lung Injury. Chest. 2022 Jul; 162(1):256-264. PMID: 35257738
-
Kearney L, Wiener RS, Dahodwala M, Fix GM, Hicks J, Little F, Howard J, Foreman AG, Wakeman C, O'Donnell C, Bulekova K, Drainoni ML, Kathuria H. A mixed methods study to inform and evaluate a longitudinal nurse practitioner/community health worker intervention to address social determinants of health and chronic obstructive pulmonary disease self-management. BMC Pulm Med. 2022 Mar 01; 22(1):74.View Related Profiles. PMID: 35232414; PMCID: PMC8889692; DOI: 10.1186/s12890-022-01863-w;
-
Eakin MN, Bauer SE, Carr T, Dagli E, Ewart G, Garfield JL, Jaspers I, Kher S, Leone FT, Melzer AC, Moazed F, Moraes TJ, Reddy KP, Upson D, Kathuria H. Policy Recommendations to Eliminate Tobacco Use and Improve Health from the American Thoracic Society Tobacco Action Committee. Ann Am Thorac Soc. 2022 02; 19(2):157-160. PMID: 34347555
-
Shenoy AT, Lyon De Ana C, Arafa EI, Salwig I, Barker KA, Korkmaz FT, Ramanujan A, Etesami NS, Soucy AM, Martin IMC, Tilton BR, Hinds A, Goltry WN, Kathuria H, Braun T, Jones MR, Quinton LJ, Belkina AC, Mizgerd JP. Antigen presentation by lung epithelial cells directs CD4+ TRM cell function and regulates barrier immunity. Nat Commun. 2021 10 05; 12(1):5834.View Related Profiles. PMID: 34611166; PMCID: PMC8492657; DOI: 10.1038/s41467-021-26045-w;
Showing 10 of 46 results.
Show More
-
Kathuria H, Leone FT. Rebuttal From Drs Kathuria and Leone. Chest. 2021 09; 160(3):812-813. PMID: 34488961
-
Kathuria H, Leone FT. COUNTERPOINT: e-Cigarette Use for Harm Reduction in Tobacco Use Disorder? No. Chest. 2021 09; 160(3):809-811. PMID: 34488959
-
Barker KA, Etesami NS, Shenoy AT, Arafa EI, Lyon de Ana C, Smith NM, Martin IM, Goltry WN, Barron AM, Browning JL, Kathuria H, Belkina AC, Guillon A, Zhong X, Crossland NA, Jones MR, Quinton LJ, Mizgerd JP. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021 06 01; 131(11).View Related Profiles. PMID: 34060477; PMCID: PMC8159694; DOI: 10.1172/JCI141810;
-
Gesthalter Y, Kathuria H, Moazed F. Smoking Cessation and Cancer. Am J Respir Crit Care Med. 2021 05 15; 203(10):P24-P25. PMID: 34014803
-
Palmer AM, Rojewski AM, Chen LS, Fucito LM, Galiatsatos P, Kathuria H, Land SR, Morgan GD, Ramsey AT, Richter KP, Wen X, Toll BA. Tobacco Treatment Program Models in US Hospitals and Outpatient Centers on Behalf of the SRNT Treatment Network. Chest. 2021 04; 159(4):1652-1663. PMID: 33259805; PMCID: PMC8039006; DOI: 10.1016/j.chest.2020.11.025;
-
-
-
Quintiliani LM, Kathuria H, Truong V, Murillo J, Borrelli B, Xuan Z, Lasser KE. Patient navigation among recently hospitalized smokers to promote tobacco treatment: Results from a randomized exploratory pilot study. Addict Behav. 2021 02; 113:106659.View Related Profiles. PMID: 33010473; PMCID: PMC7946867; DOI: 10.1016/j.addbeh.2020.106659;
-
Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, Fennig K, Folan P, Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, Pakhale S, Prezant D, Sachs DPL, Toll B, Upson D, Xiao D, Cruz-Lopes L, Fulone I, Murray RL, O'Brien KK, Pavalagantharajah S, Ross S, Zhang Y, Zhu M, Farber HJ. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 07 15; 202(2):e5-e31. PMID: 32663106; PMCID: PMC7365361; DOI: 10.1164/rccm.202005-1982ST;
-
Herbst N, Wiener RS, Helm ED, O'Donnell C, Fitzgerald C, Wong C, Bulekova K, Waite M, Mishuris RG, Kathuria H. Effectiveness of an Opt-Out Electronic Heath Record-Based Tobacco Treatment Consult Service at an Urban Safety Net Hospital. Chest. 2020 10; 158(4):1734-1741.View Related Profiles. PMID: 32428510
-
-
Golden SE, Ono SS, Melzer A, Davis J, Zeliadt SB, Heffner JL, Kathuria H, Garcia-Alexander G, Slatore CG. "I Already Know That Smoking Ain't Good for Me": Patient and Clinician Perspectives on Lung Cancer Screening Decision-Making Discussions as a Teachable Moment. Chest. 2020 09; 158(3):1250-1259. PMID: 32304776
-
-
Kathuria H, Koppelman E, Borrelli B, Slatore CG, Clark JA, Lasser KE, Wiener RS. Patient-Physician Discussions on Lung Cancer Screening: A Missed Teachable Moment to Promote Smoking Cessation. Nicotine Tob Res. 2020 03 16; 22(3):431-439.View Related Profiles. PMID: 30476209; PMCID: PMC7297104; DOI: 10.1093/ntr/nty254;
-
Reddy K, Kher S, Kathuria H. Prescription Medications to Help You Stop Smoking. Am J Respir Crit Care Med. 2020 03 15; 201(6):P11-P12. PMID: 32167378
-
Kathuria H, Neptune E. Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment. Clin Chest Med. 2020 03; 41(1):39-51. PMID: 32008628
-
Seth B, Herbst N, Oleinik K, Clark K, Helm ED, O'Donnell C, Fitzgerald C, Wong C, Wiener RS, Kathuria H. Feasibility, Acceptability, and Adoption of an Inpatient Tobacco Treatment Service at a Safety-Net Hospital: A Mixed-Methods Study. Ann Am Thorac Soc. 2020 01; 17(1):63-71.View Related Profiles. PMID: 31593497
-
Kathuria H, Seibert RG, Cobb V, Weinstein ZM, Gowarty M, Helm ED, Wiener RS. Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods Study. J Addict Med. 2019 Sep/Oct; 13(5):338-345.View Related Profiles. PMID: 31232740
-
Charlot M, D'Amico S, Luo M, Gemei A, Kathuria H, Gardiner P. Feasibility and Acceptability of Mindfulness-Based Group Visits for Smoking Cessation in Low-Socioeconomic Status and Minority Smokers with Cancer. J Altern Complement Med. 2019 Jul; 25(7):762-769.View Related Profiles. PMID: 31314565
-
Kathuria H, Seibert RG, Cobb V, Herbst N, Weinstein ZM, Gowarty M, Jhunjhunwala R, Helm ED, Wiener RS. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study. Addict Behav. 2019 08; 95:41-48.View Related Profiles. PMID: 30836208; DOI: 10.1016/j.addbeh.2019.02.017;
-
Iaccarino JM, Duran C, Slatore CG, Wiener RS, Kathuria H. Combining smoking cessation interventions with LDCT lung cancer screening: A systematic review. Prev Med. 2019 04; 121:24-32.View Related Profiles. PMID: 30753860
-
Leone FT, Carlsen KH, Chooljian D, Crotty Alexander LE, Detterbeck FC, Eakin MN, Evers-Casey S, Farber HJ, Folan P, Kathuria H, Latzka K, McDermott S, McGrath-Morrow S, Moazed F, Munzer A, Neptune E, Pakhale S, Sachs DPL, Samet J, Sufian B, Upson D. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med. 2018 10 15; 198(8):e90-e105. PMID: 30320525; PMCID: PMC6943880; DOI: 10.1164/rccm.201808-1443ST;
-
-
Kathuria H, Leone FT, Neptune ER. Treatment of tobacco dependence: current state of the art. Curr Opin Pulm Med. 2018 07; 24(4):327-334. PMID: 29677028
-
Millien G, Cao Y, O'Hara CJ, Tagne JB, Hinds A, Williams MC, Ramirez MI, Kathuria H. ETS1 regulates Twist1 transcription in a KrasG12D/Lkb1-/- metastatic lung tumor model of non-small cell lung cancer. Clin Exp Metastasis. 2018 03; 35(3):149-165.View Related Profiles. PMID: 29909489
-
Kathuria H. Proactively Engaging Smokers with Chronic Respiratory Disease in Tobacco Treatment. Ann Am Thorac Soc. 2018 03; 15(3):308-309. PMID: 29493333
-
Wiener RS, Koppelman E, Bolton R, Lasser KE, Borrelli B, Au DH, Slatore CG, Clark JA, Kathuria H. Patient and Clinician Perspectives on Shared Decision-making in Early Adopting Lung Cancer Screening Programs: a Qualitative Study. J Gen Intern Med. 2018 07; 33(7):1035-1042.View Related Profiles. PMID: 29468601; PMCID: PMC6025674; DOI: 10.1007/s11606-018-4350-9;
-
Muñoz-Largacha JA, Steiling KA, Kathuria H, Charlot M, Fitzgerald C, Suzuki K, Litle VR. Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital. J Thorac Cardiovasc Surg. 2018 06; 155(6):2674-2681.View Related Profiles. PMID: 29534906
-
Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2017 Nov 01; 196(9):1202-1212.View Related Profiles. PMID: 29090963; PMCID: PMC6072613; DOI: 10.1164/rccm.201709-1858ST;
-
-
-
Boopathi E, Gomes CM, Goldfarb R, John M, Srinivasan VG, Alanzi J, Malkowicz SB, Kathuria H, Zderic SA, Wein AJ, Chacko S. Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings. Am J Pathol. 2011 May; 178(5):2236-51. PMID: 21514437; PMCID: PMC3081182; DOI: 10.1016/j.ajpath.2011.01.038;
-
Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O'Hara CJ, Kathuria S, Ramirez MI, Williams MC, Kathuria H. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis. 2009 Aug; 30(8):1433-42.View Related Profiles. PMID: 19483189; PMCID: PMC2718075; DOI: 10.1093/carcin/bgp129;
-
Kathuria H, Cao Y, Hinds A, Ramirez MI, Williams MC. ERM is expressed by alveolar epithelial cells in adult mouse lung and regulates caveolin-1 transcription in mouse lung epithelial cell lines. J Cell Biochem. 2007 Sep 1; 102(1):13-27.View Related Profiles. PMID: 17390339
-
Kathuria H, Cao YX, Ramirez MI, Williams MC. Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ETS proteins in epithelial cell expression. J Biol Chem. 2004 Jul 16; 279(29):30028-36.View Related Profiles. PMID: 15138262
-
Nasreen N, Mohammed KA, Hardwick J, Van Horn RD, Sanders K, Kathuria H, Loghmani F, Antony VB. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis. Oncol Res. 2002; 13(2):71-8. PMID: 12392154
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 13 |
| 2021 | 5 |
| 2022 | 9 |
2022 American Thoracic Society:
Chair, Tobacco Action Committee, American Thoracic Society (ATS)
2022 American Thoracic Society:
Chair, Planning Committee, Thoracic Oncology Assembly, ATS)
2020 UpToDate:
Section Editor, UpToDate, Tobacco Treatment Section
2020-2021 BU:
BU-Tobacco Regulatory Science ARC Pilot Project Award
2019-2021 American Thoracic Society:
Vice-Chair, Tobacco Action Committee, American Thoracic Society (ATS)
2019 BUMC:
Alan Fine Award for Unique Contributions and Creativity to the Pulmonary Section
2019 BUMC:
Evans Clinician Designation title, Evans Foundation
2019 CHEST:
Editorial Board for CHEST, Thoracic Oncology-Prevention Section
2018-2019 BUSM:
Awardee, Mid-Career Faculty Leadership Program
2018 American Thoracic Society:
Fellow Status, American Thoracic Society (ATSF)
2018 BUMC:
BU-CIIS Pilot Grant Program Award
2018-2019 BU:
BU-Mobile Health ARC Pilot Project Award
2018-2020 American College of Chest Physicians:
American College of Chest Physicians Award: Guideline Development of Inpatient Tobacco Treatment
2017 BMC:
Be Exceptional Award in Performance and Commitment to BMC Care
2017-2019 American Lung Association:
Lung Cancer Discovery Award
2016-2016 American Thoracic Society:
ATS Assembly/Committee Project Award for Research Policy Statement development on Smoking Cessation
2016 American Thoracic Society:
ATS Tobacco Action Committee, Appointment
2016 BUSM:
Clinical Innovator Award, Evans Foundation
2016 BMC:
Clinical Quality Improvement Award, Lung Cancer Screening
2016-2017 American Thoracic Society:
American Thoracic Society Assembly/Committee Project Award for Research Policy Statement
2015-2016 BU CTSI:
BU CTSI Team Science Pilot Grant Program Award, Co-PI
2013-2015 Department of Defense:
DOD Lung Cancer Research Concept Award
2013 BUMC:
L. Jack Faling Award for Excellence in Teaching, Boston University Pulmonary Center
2011 American Thoracic Society:
ATS Section on Thoracic Oncology Assembly Research Excellence Award
2010-2013 DOD:
DOD Lung Cancer Promising Clinician Research Award